ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 49488 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 49488; 2) Community: the network communities that were significantly associated with the response to NSC 49488; 3) Molecule: the relationships between components within communities and NSC 49488; 4) MDR: the compounds that were significantly associated with the NSC 49488.

NSC Compound Enrichment Correlation
NSC 94600 Camptothecin 0.0115521552688258 0.34229288
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0123744972338279 -0.054374165
NSC 743962 Null 0.0123744972338279 -0.17825218
NSC 748900 [(20S)-20-(N,N-dimethylamino)-3a-(tigloylamino)-5a-preg-2a -O-acetate-4a-ol] 0.0123744972338279 0.16113163
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.012374497233828 0.18311031
NSC 39135 Null 0.012374497233828 0.23240499
NSC 58239 A 80021F34 0.0123744972338281 0.29105883
NSC 682756 Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- 0.0123744972338281 0.11671386
NSC 107124 Camptothecin Derivative 0.0140755620492158 0.39444318
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0140755620492158 0.27908317
Total:53  Current:15    [First] [Prev] [Next] [Last]